biotech AGM shareholder vote
Inside NurExone’s Push Into Eye and Skin Applications for Its Exosome Platform
NurExone’s exosomes are good at finding damaged tissue. Getting them past the skin’s outer barrier without breaking apart along the way is a separate problem entirely. This week the company partnered with an Israeli device maker that already has an FDA-cleared answer to exactly that problem, the same week its shareholders quietly handed the board…
